PubMed

Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS.

Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, Powderly WG, Hafner R, Kauffman CA, Dismukes WE; U.S. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Ann Intern Med. 2002 Jul 16;137(2):105-9.PMID: 12118965 [PubMed - indexed for MEDLINE]Related articlesFree article

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.

N Engl J Med. 1999 Mar 11;340(10):764-71.PMID: 10072411 [PubMed - indexed for MEDLINE]Related articlesFree article

Clearance of fungal burden during treatment of disseminated histoplasmosis with liposomal amphotericin B versus itraconazole.

Wheat LJ, Cloud G, Johnson PC, Connolly P, Goldman M, Le Monte A, Fuller DE, Davis TE, Hafner R; AIDS Clinical Trials Group; Mycoses Study Group of NIAID.

Antimicrob Agents Chemother. 2001 Aug;45(8):2354-7.PMID: 11451696 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Treatment of histoplasmosis in patients with HIV infection.

[No authors listed]

Ann Intern Med. 2002 Jul 16;137(2):I54. No abstract available. PMID: 12118987 [PubMed - indexed for MEDLINE]Related articlesFree article

Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Leenders AC, Reiss P, Portegies P, Clezy K, Hop WC, Hoy J, Borleffs JC, Allworth T, Kauffmann RH, Jones P, Kroon FP, Verbrugh HA, de Marie S.

AIDS. 1997 Oct;11(12):1463-71.PMID: 9342068 [PubMed - indexed for MEDLINE]Related articles

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.

N Engl J Med. 2004 Sep 30;351(14):1391-402.PMID: 15459300 [PubMed - indexed for MEDLINE]Related articlesFree article

Liposomal amphotericin B versus conventional amphotericin B in the empirical treatment of persistently febrile neutropenic patients.

Cagnoni PJ.

J Antimicrob Chemother. 2002 Feb;49 Suppl 1:81-6. Review.PMID: 11801587 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.

Prentice HG, Hann IM, Herbrecht R, Aoun M, Kvaloy S, Catovsky D, Pinkerton CR, Schey SA, Jacobs F, Oakhill A, Stevens RF, Darbyshire PJ, Gibson BE.

Br J Haematol. 1997 Sep;98(3):711-8.PMID: 9332329 [PubMed - indexed for MEDLINE]Related articles

Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.

Wheat J, Hafner R, Wulfsohn M, Spencer P, Squires K, Powderly W, Wong B, Rinaldi M, Saag M, Hamill R, Murphy R, Connolly-Stringfield P, Briggs N, Owens S; National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators.

Ann Intern Med. 1993 Apr 15;118(8):610-6.PMID: 8383934 [PubMed - indexed for MEDLINE]Related articlesFree article

Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group.

Wheat J, Hafner R, Korzun AH, Limjoco MT, Spencer P, Larsen RA, Hecht FM, Powderly W.

Am J Med. 1995 Apr;98(4):336-42.PMID: 7709945 [PubMed - indexed for MEDLINE]Related articles

Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group.

Wheat J, MaWhinney S, Hafner R, McKinsey D, Chen D, Korzun A, Shakan KJ, Johnson P, Hamill R, Bamberger D, Pappas P, Stansell J, Koletar S, Squires K, Larsen RA, Cheung T, Hyslop N, Lai KK, Schneider D, Kauffman C, Saag M, Dismukes W, Powderly W.

Am J Med. 1997 Sep;103(3):223-32.PMID: 9316555 [PubMed - indexed for MEDLINE]Related articles

Liposomal amphotericin B for the treatment of severe fungal infection.

Michaud D.

Dynamics. 2001 Spring;12(1):17-21. Review.PMID: 11982230 [PubMed - indexed for MEDLINE]Related articles

Liposomal amphotericin B therapy of murine histoplasmosis.

Graybill JR, Bocanegra R.

Antimicrob Agents Chemother. 1995 Aug;39(8):1885-7.PMID: 7486941 [PubMed - indexed for MEDLINE]Related articlesFree article

Antimycotic therapy with liposomal amphotericin-B for patients undergoing bone marrow or peripheral blood stem cell transplantation.

Krüger W, Stockschläder M, Sobottka I, Betker R, De Wit M, Kröger N, Grimm J, Arland M, Fiedler W, Erttmann R, Zander AR.

Leuk Lymphoma. 1997 Feb;24(5-6):491-9.PMID: 9086439 [PubMed - indexed for MEDLINE]Related articles

Liposomal amphotericin B. Therapeutic use in the management of fungal infections and visceral leishmaniasis.

Coukell AJ, Brogden RN.

Drugs. 1998 Apr;55(4):585-612. Review.PMID: 9561346 [PubMed - indexed for MEDLINE]Related articles

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial).

Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Ullmann AJ, Bouza E, Heussel CP, Lortholary O, Rieger C, Boehme A, Aoun M, Horst HA, Thiebaut A, Ruhnke M, Reichert D, Vianelli N, Krause SW, Olavarria E, Herbrecht R; AmBiLoad Trial Study Group.

Clin Infect Dis. 2007 May 15;44(10):1289-97. Epub 2007 Apr 9.PMID: 17443465 [PubMed - indexed for MEDLINE]Related articles

Open label, randomised, comparative phase III safety and efficacy study with conventional amphotericin B and liposomal amphotericin B in patients with systemic fungal infection.

Bodhe PV, Kotwani RN, Kirodian BG, Kshirsagar NA, Pandya SK.

J Assoc Physicians India. 2002 May;50(5):662-70.PMID: 12186120 [PubMed - indexed for MEDLINE]Related articles

[Meta-analysis on safety and efficacy of liposomal amphotericin B in the empirical treatment of febrile neutropenia]

Badia X, Roset M, Carreras E, Ausin I, Herrera L.

Med Clin (Barc). 2004 May 1;122(16):610-6. Review. Spanish. PMID: 15142508 [PubMed - indexed for MEDLINE]Related articles

[Liposomal amphotericin B in the treatment of severe fungal infections. Results of a clinical cohort trial]

Rieger CT, Dittmer M, Ostermann H.

Dtsch Med Wochenschr. 2007 Oct;132(40):2062-6. German. PMID: 17899499 [PubMed - indexed for MEDLINE]Related articles

A prospective and retrospective analysis of the nephrotoxicity and efficacy of lipid-based amphotericin B formulations.

Cannon JP, Garey KW, Danziger LH.

Pharmacotherapy. 2001 Sep;21(9):1107-14.PMID: 11560200 [PubMed - indexed for MEDLINE]Related articles